| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Parsons Erin serves as a Director at KPRX. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $26K at current prices.
The biggest single holding is KPRX (~$26K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 5,260 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2024 | KPRX Kiora Pharmaceuticals Inc | Director | Buy | 5,260 | $4.88 | $25,668.80 | New | -26.0% | -37.6% |